Cargando…

In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice

Antiretroviral therapy (ART) in pregnancy has dramatically reduced HIV vertical transmission rates. Consequently, there is a growing number of children that are HIV exposed uninfected (CHEUs). Studies suggest that CHEUs exposed in utero to ART may experience developmental delays compared to their pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarkar, Ambalika, Balogun, Kayode, Guzman Lenis, Monica S., Acosta, Sebastian, Mount, Howard T., Serghides, Lena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676697/
https://www.ncbi.nlm.nih.gov/pubmed/33211746
http://dx.doi.org/10.1371/journal.pone.0242513
_version_ 1783611825262166016
author Sarkar, Ambalika
Balogun, Kayode
Guzman Lenis, Monica S.
Acosta, Sebastian
Mount, Howard T.
Serghides, Lena
author_facet Sarkar, Ambalika
Balogun, Kayode
Guzman Lenis, Monica S.
Acosta, Sebastian
Mount, Howard T.
Serghides, Lena
author_sort Sarkar, Ambalika
collection PubMed
description Antiretroviral therapy (ART) in pregnancy has dramatically reduced HIV vertical transmission rates. Consequently, there is a growing number of children that are HIV exposed uninfected (CHEUs). Studies suggest that CHEUs exposed in utero to ART may experience developmental delays compared to their peers. We investigated the effects of in utero ART exposure on perinatal neurodevelopment in mice, through assessment of developmental milestones. Developmental milestone tests (parallel to reflex testing in human infants) are reflective of brain maturity and useful in predicting later behavioral outcomes. We hypothesized that ART in pregnancy alters the in utero environment and thereby alters developmental milestone outcomes in pups. Throughout pregnancy, dams were treated with boosted-atazanavir combined with either abacavir/lamivudine (ATV/r/ABC/3TC), or tenofovir/emtricitabine (ATV/r/TDF/FTC), or water as control. Pups were assessed daily for general somatic growth and on a battery of tests for primitive reflexes including surface-righting, negative-geotaxis, cliff-aversion, rooting, ear-twitch, auditory-reflex, forelimb-grasp, air-righting, behaviors in the neonatal open field, and olfactory test. In utero exposure to either ART regimen delayed somatic growth in offspring and evoked significant delays in the development of negative geotaxis, cliff-aversion, and ear-twitch reflexes. Exposure to ATV/r/ABC/3TC was also associated with olfactory deficits in male and forelimb grasp deficits in female pups. To explore whether delays persisted into adulthood we assessed performance in the open field test. We observed no significant differences between treatment arm for males. In females, ATV/r/TDF/FTC exposure was associated with lower total distance travelled and less ambulatory time in the centre, while ATV/r/ABC/3TC exposure was associated with higher resting times compared to controls. In utero PI-based ART exposure delays the appearance of primitive reflexes that involve vestibular and sensory-motor pathways in a mouse model. Our findings suggest that ART could be disrupting the normal progress/maturation of the underlying neurocircuits and encourage further investigation for underlying mechanisms.
format Online
Article
Text
id pubmed-7676697
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-76766972020-12-02 In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice Sarkar, Ambalika Balogun, Kayode Guzman Lenis, Monica S. Acosta, Sebastian Mount, Howard T. Serghides, Lena PLoS One Research Article Antiretroviral therapy (ART) in pregnancy has dramatically reduced HIV vertical transmission rates. Consequently, there is a growing number of children that are HIV exposed uninfected (CHEUs). Studies suggest that CHEUs exposed in utero to ART may experience developmental delays compared to their peers. We investigated the effects of in utero ART exposure on perinatal neurodevelopment in mice, through assessment of developmental milestones. Developmental milestone tests (parallel to reflex testing in human infants) are reflective of brain maturity and useful in predicting later behavioral outcomes. We hypothesized that ART in pregnancy alters the in utero environment and thereby alters developmental milestone outcomes in pups. Throughout pregnancy, dams were treated with boosted-atazanavir combined with either abacavir/lamivudine (ATV/r/ABC/3TC), or tenofovir/emtricitabine (ATV/r/TDF/FTC), or water as control. Pups were assessed daily for general somatic growth and on a battery of tests for primitive reflexes including surface-righting, negative-geotaxis, cliff-aversion, rooting, ear-twitch, auditory-reflex, forelimb-grasp, air-righting, behaviors in the neonatal open field, and olfactory test. In utero exposure to either ART regimen delayed somatic growth in offspring and evoked significant delays in the development of negative geotaxis, cliff-aversion, and ear-twitch reflexes. Exposure to ATV/r/ABC/3TC was also associated with olfactory deficits in male and forelimb grasp deficits in female pups. To explore whether delays persisted into adulthood we assessed performance in the open field test. We observed no significant differences between treatment arm for males. In females, ATV/r/TDF/FTC exposure was associated with lower total distance travelled and less ambulatory time in the centre, while ATV/r/ABC/3TC exposure was associated with higher resting times compared to controls. In utero PI-based ART exposure delays the appearance of primitive reflexes that involve vestibular and sensory-motor pathways in a mouse model. Our findings suggest that ART could be disrupting the normal progress/maturation of the underlying neurocircuits and encourage further investigation for underlying mechanisms. Public Library of Science 2020-11-19 /pmc/articles/PMC7676697/ /pubmed/33211746 http://dx.doi.org/10.1371/journal.pone.0242513 Text en © 2020 Sarkar et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Sarkar, Ambalika
Balogun, Kayode
Guzman Lenis, Monica S.
Acosta, Sebastian
Mount, Howard T.
Serghides, Lena
In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice
title In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice
title_full In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice
title_fullStr In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice
title_full_unstemmed In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice
title_short In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice
title_sort in utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676697/
https://www.ncbi.nlm.nih.gov/pubmed/33211746
http://dx.doi.org/10.1371/journal.pone.0242513
work_keys_str_mv AT sarkarambalika inuteroexposuretoproteaseinhibitorbasedantiretroviralregimensdelaysgrowthanddevelopmentalmilestonesinmice
AT balogunkayode inuteroexposuretoproteaseinhibitorbasedantiretroviralregimensdelaysgrowthanddevelopmentalmilestonesinmice
AT guzmanlenismonicas inuteroexposuretoproteaseinhibitorbasedantiretroviralregimensdelaysgrowthanddevelopmentalmilestonesinmice
AT acostasebastian inuteroexposuretoproteaseinhibitorbasedantiretroviralregimensdelaysgrowthanddevelopmentalmilestonesinmice
AT mounthowardt inuteroexposuretoproteaseinhibitorbasedantiretroviralregimensdelaysgrowthanddevelopmentalmilestonesinmice
AT serghideslena inuteroexposuretoproteaseinhibitorbasedantiretroviralregimensdelaysgrowthanddevelopmentalmilestonesinmice